EDOG - Institut Bergonie - PPDS

Bordeaux, Gironde 33000

1 studies enrolling now · 3 studies all time

What they study most

HER2 Amplification, HER2 Gene Mutation, HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, Metastatic Castration-Resistant Prostate Cancer, Solid Tumors

Studies at this site

• A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers — Running, not enrolling
• ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer — Running, not enrolling